Title | The Role of Apelin in the Retina of Diabetic Rats |
Authors | Lu, Qiang Feng, Jing Jiang, Yan-rong |
Affiliation | Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100871, Peoples R China. Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China. |
Keywords | ENDOTHELIAL GROWTH-FACTOR APJ RECEPTOR CELL-PROLIFERATION ENDOGENOUS LIGAND ANGIOGENIC FACTOR EXPRESSION RETINOPATHY PEPTIDE MICE VITREORETINOPATHY |
Issue Date | 2013 |
Publisher | plos one |
Citation | PLOS ONE.2013,8,(7). |
Abstract | Purpose: Apelin is a novel adipocytokine participating in diabetes, but its role in diabetic retinopathy (DR) is unknown. Our study aimed to investigate the effect of apelin on the proliferative potential in DR along with its antagonist inhibitory effects. Principal Findings: Strong staining of apelin, co-localized with glial fibrillary acidic protein (GFAP) and vascular endothelial growth factor (VEGF) was observed in the retina of diabetic rats. Apelin, GFAP, and VEGF mRNA and protein levels were significantly increased in the sample's retinas. Moreover, exogenous apelin promoted retinal Muller cell proliferation in vivo. Simultaneously, apelin induced GFAP and VEGF expression. F13A markedly reduced retinal gliosis caused by diabetes. Furthermore, F13A suppressed both GFAP and VEGF expression in vivo. Significance: Our results strongly suggest that apelin is associated with the development of DR and contributes to changes in the retinas of diabetic rats. Apelin induced promotion of cell proliferation lends support to the possibility that apelin may play a role in the progression of DR to a proliferative phase. This possible role deserves further investigation, which may offer new perspectives in the early prevention and treatment of DR. |
URI | http://hdl.handle.net/20.500.11897/307120 |
ISSN | 1932-6203 |
DOI | 10.1371/journal.pone.0069703 |
Indexed | SCI(E) PubMed |
Appears in Collections: | 人民医院 |